MYND Life Sciences (XCNQ:MYND) ROCE % : 0.00% (As of Jul. 2024)

View and export this data going back to 2021. Start your Free Trial

What is MYND Life Sciences ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. MYND Life Sciences's annualized ROCE % for the quarter that ended in Jul. 2024 was 0.00%.

MYND Life Sciences ROCE % Historical Data

The historical data trend for MYND Life Sciences's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MYND Life Sciences ROCE % Chart

MYND Life Sciences Annual Data

Trend

Oct21

Oct22

Oct23

ROCE %

-190.11

MYND Life Sciences Quarterly Data
	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
ROCE %	Get a 7-Day Free Trial										-	-	-	-	-

MYND Life Sciences ROCE % Calculation

MYND Life Sciences's annualized ROCE % for the fiscal year that ended in Oct. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Oct. 2023 )		(A: Oct. 2022 )		(A: Oct. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Oct. 2023 )		(A: Oct. 2022 )		(A: Oct. 2023 )
	=	-0.786	/	( ( (0.654 - 4.127)	+	(0.798 - 5.775) )	/ 2 )
	=	-0.786	/	( (-3.473	+	-4.977)	/ 2 )
	=	-0.786	/	-4.225
	=	18.60 %

MYND Life Sciences's ROCE % of for the quarter that ended in Jul. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jul. 2024 )		(Q: Apr. 2024 )		(Q: Jul. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jul. 2024 )		(Q: Apr. 2024 )		(Q: Jul. 2024 )
	=	-1.368	/	( ( (0.708 - 6.317)	+	(0.72 - 6.708) )	/ 2 )
	=	-1.368	/	( ( -5.609	+	-5.988 )	/ 2 )
	=	-1.368	/	-5.7985
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Jul. 2024) EBIT data.

MYND Life Sciences (XCNQ:MYND) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

MYND Life Sciences ROCE % Related Terms

Thank you for viewing the detailed overview of MYND Life Sciences's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

MYND Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MYND Life Sciences Inc (XCNQ:MYND) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

MYNDF:USA

Address

105-2248 Elgin Avenue, Port Coquitlam, BC, CAN, V3C 2B2

Website

https://www.myndsciences.com

MYND Life Sciences Inc is a medical biotech drug research and development company. The company is focused on neuro pharmaceutical and novel drug development, diagnostics, and vaccines and is developing new biological entities (NBEs) and new chemical entities (NCEs) and differentiates itself from other (bio)pharmaceutical companies by different molecular concepts for the applications of psilocybin analogs for overcoming diseases.